Santiago Gisler,  —

ProAir Digihaler Approved for COPD and Asthma Patients to Digitally Track Their Albuterol Use

The ProAir Digihaler, a digital inhaler that allows patients with asthma and chronic obstructive pulmonary disease (COPD) to track their inhaler usage through a mobile app, has been approved by the U.S. Food and Drug Administration (FDA), its developer Teva Pharmaceuticals announced. The albuterol inhaler (albuterol sulfate, 117 micrograms)…

Few COPD Patients Enroll in Pulmonary Rehabilitation, Despite Benefits, Study Shows

Very few patients with chronic obstructive pulmonary disease (COPD) start pulmonary rehabilitation after being hospitalized, despite its proven benefits and clinical guidelines recommending it shortly after discharge, a study shows. Study results were published in the journal Annals of the American Thoracic Society, in an article titled “…